Ligand Pharmaceuticals Inc (LGND)
70.37
-0.63
(-0.89%)
USD |
NASDAQ |
Apr 25, 16:00
70.26
-0.11
(-0.16%)
After-Hours: 20:00
Ligand Pharmaceuticals Cash from Investing (TTM): -11.68M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -11.68M |
| September 30, 2023 | -8.682M |
| June 30, 2023 | 30.00M |
| March 31, 2023 | 60.29M |
| December 31, 2022 | 163.62M |
| September 30, 2022 | 135.20M |
| June 30, 2022 | 97.80M |
| March 31, 2022 | 79.29M |
| December 31, 2021 | 30.52M |
| September 30, 2021 | -315.97M |
| June 30, 2021 | 34.32M |
| March 31, 2021 | -11.77M |
| December 31, 2020 | 231.65M |
| September 30, 2020 | 550.67M |
| June 30, 2020 | 388.12M |
| March 31, 2020 | 680.68M |
| December 31, 2019 | 466.92M |
| September 30, 2019 | 805.40M |
| June 30, 2019 | 557.63M |
| March 31, 2019 | -294.91M |
| December 31, 2018 | -423.27M |
| September 30, 2018 | -734.74M |
| June 30, 2018 | -713.03M |
| March 31, 2018 | -87.09M |
| December 31, 2017 | -79.18M |
| Date | Value |
|---|---|
| September 30, 2017 | -120.96M |
| June 30, 2017 | -59.34M |
| March 31, 2017 | -80.32M |
| December 31, 2016 | -134.42M |
| September 30, 2016 | -67.94M |
| June 30, 2016 | -99.38M |
| March 31, 2016 | -189.82M |
| December 31, 2015 | -112.86M |
| September 30, 2015 | -103.10M |
| June 30, 2015 | -76.66M |
| March 31, 2015 | -3.826M |
| December 31, 2014 | -2.027M |
| September 30, 2014 | -1.319M |
| June 30, 2014 | -1.637M |
| March 31, 2014 | -5.938M |
| December 31, 2013 | -4.974M |
| September 30, 2013 | -4.043M |
| June 30, 2013 | -6.166M |
| March 31, 2013 | -2.716M |
| December 31, 2012 | 1.263M |
| September 30, 2012 | -0.944M |
| June 30, 2012 | 1.287M |
| March 31, 2012 | 1.982M |
| December 31, 2011 | -25.13M |
| September 30, 2011 | -21.82M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-315.97M
Minimum
Sep 2021
805.40M
Maximum
Sep 2019
208.63M
Average
97.80M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
| ANI Pharmaceuticals Inc | -18.51M |
| ADMA Biologics Inc | -4.981M |
| Viking Therapeutics Inc | -641.08M |
| Corcept Therapeutics Inc | 90.91M |
| Palatin Technologies Inc | 9.293M |